Prosecution Insights
Last updated: October 27, 2026

Matthew R Keogh, USPTO Patent Examiner

Listed by the USPTO as KEOGH, MATTHEW R

Tech Center 1600 • Art Units: 1638 1663

This examiner grants 78% of resolved cases

Analysis

KEOGH, MATTHEW R is a USPTO patent examiner in tech center 1600 and art unit 1638. The record reports 717 resolved cases, an allowance rate of 78.5%, and a median of 965 days to allowance. The interview lift is 14.4%, indicating that interviews may assist prosecution but do not dominate the measured outcome.

The leading companies are Pioneer Hi-bred International Inc., Inari Agriculture Technology Inc., and Syngenta AG. The leading firms are MCKEE, VOORHEES & SEASE, P.L.C., ARENTFOX SCHIFF LLP, and DENTONS US LLP. Counsel should emphasize technically precise written responses, use interviews for targeted clarification, and consider the recorded allowance timing when coordinating examination with research, product, or portfolio decisions.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

78.5%
Allow Rate
+18.5% vs TC avg
752
Total Applications
+14.4%
Interview Lift
965
Avg Prosecution Days
Based on 717 resolved cases, 2023–2026

Rejection Statute Breakdown

6.4%
§101 Eligibility
15.2%
§102 Novelty
25.7%
§103 Obviousness
42.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19372398 METHODS AND COMPOSITIONS FOR THE INTRODUCTION AND REGULATED EXPRESSION OF GENES IN PLANTS Non-Final OA PIONEER HI-BRED INTERNATIONAL, INC.
19220291 USE OF MORPHOGENIC FACTORS FOR THE IMPROVEMENT OF GENE EDITING Non-Final OA PIONEER HI-BRED INTERNATIONAL, INC.
18167247 SOYBEAN VARIETY 5PUDM32 Final Rejection PIONEER HI-BRED INTERNATIONAL, INC.
18067345 GENERATING MAIZE PLANTS WITH ENHANCED RESISTANCE TO NORTHERN LEAF BLIGHT Non-Final OA PIONEER HI-BRED INTERNATIONAL, INC.
17760273 CAS-MEDIATED HOMOLOGY DIRECTED REPAIR IN SOMATIC PLANT TISSUE Final Rejection PIONEER HI-BRED INTERNATIONAL, INC.
17052320 METHODS AND COMPOSITIONS FOR HOMOLOGY-DIRECTED REPAIR OF CAS ENDONUCLEASE MEDIATED DOUBLE STRAND BREAKS Final Rejection PIONEER HI-BRED INTERNATIONAL, INC.
19041097 SOYBEAN VARIETY Final Rejection SYNGENTA CROP PROTECTION AG
18495805 VARIETY CORN LINE HID2388 Non-Final OA SYNGENTA CROP PROTECTION AG
18705253 TRANSCRIPTION REGULATING NUCLEOTIDE SEQUENCES AND METHODS OF USE Final Rejection BASF Agricultural Solutions Seed US LLC
18677865 Soybean Cultivar 3284306 Non-Final OA Confluence Genetics, LLC
19197017 INIR20 TRANSGENIC SOYBEAN WITH JUNCTION POLYNUCLEOTIDE DELETIONS Non-Final OA INARI AGRICULTURE TECHNOLOGY, INC.
19078091 INIR6 TRANSGENIC MAIZE Non-Final OA INARI AGRICULTURE TECHNOLOGY, INC.
18481358 INIR11 TRANSGENIC MAIZE WITH JUNCTION SEQUENCE DELETIONS Final Rejection INARI AGRICULTURE TECHNOLOGY, INC.
18780938 COMPOSITIONS AND METHODS FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING ALTERED ALKALOID LEVELS Final Rejection Altria Client Services LLC
19303663 METHODS AND COMPOSITIONS FOR THE MODIFICATION OF PLANTS Non-Final OA Flagship Pioneering Innovations VI, LLC
19283275 PagPB GENE REGULATING NITROGEN ABSORPTION AND UTILIZATION IN ROOT SYSTEM OF WOODY PLANT AND APPLICATION THEREOF Non-Final OA Research Institute of Forestry, Chinese Academy of Forestry
18704380 HETERODIMERIC BENZALDEHYDE SYNTHASE, METHODS OF PRODUCING, AND USES THEREOF Non-Final OA Purdue Research Foundation
19021762 CANOLA HYBRID 22CN0178 Non-Final OA BASF Agricultural Solutions US LLC
17555737 Canola Hybrid Variety 9CN0103 Non-Final OA BASF Agricultural Solutions US LLC
18737058 METHOD TO INCREASE POLLEN FERTILITY Final Rejection Keygene N.V.
18538893 METHODS AND COMPOSITIONS FOR USE OF DIRECTED RECOMBINATION IN PLANT BREEDING Final Rejection Monsanto Technology LLC
18377421 COMPOSITIONS AND METHODS FOR TRANSFORMATION OF EMBRYO EXPLANT POPULATIONS Non-Final OA Monsanto Technology LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Matthew R Keogh's allowance rate?

78.5% of resolved applications examined by Matthew R Keogh were allowed (717 resolved cases), compared with 48.8% across Art Unit 1638 over the last five years.

Does an interview help with examiner Matthew R Keogh?

This examiner's interview lift is +14.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Matthew R Keogh take to allow a patent?

Applications allowed by Matthew R Keogh took 965 days on average from filing to allowance.

Which art unit does examiner Matthew R Keogh work in?

Matthew R Keogh examines applications in Art Unit 1638 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month